Canada markets closed

BridgeBio Pharma, Inc. (BBIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
27.83+0.09 (+0.32%)
At close: 04:00PM EDT
27.86 +0.03 (+0.11%)
After hours: 07:53PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 5.21B
Enterprise Value 6.42B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)21.55
Price/Book (mrq)N/A
Enterprise Value/Revenue 29.35
Enterprise Value/EBITDA -14.09

Trading Information

Stock Price History

Beta (5Y Monthly) 1.03
52-Week Change 3105.18%
S&P500 52-Week Change 322.38%
52 Week High 344.32
52 Week Low 312.75
50-Day Moving Average 328.77
200-Day Moving Average 330.86

Share Statistics

Avg Vol (3 month) 31.7M
Avg Vol (10 day) 31.6M
Shares Outstanding 5187.13M
Implied Shares Outstanding 6187.13M
Float 8115.78M
% Held by Insiders 15.27%
% Held by Institutions 191.92%
Shares Short (Apr 15, 2024) 415.07M
Short Ratio (Apr 15, 2024) 49.67
Short % of Float (Apr 15, 2024) 412.43%
Short % of Shares Outstanding (Apr 15, 2024) 48.06%
Shares Short (prior month Mar 15, 2024) 413.41M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -246.23%
Operating Margin (ttm)1.77%

Management Effectiveness

Return on Assets (ttm)-40.08%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)218.6M
Revenue Per Share (ttm)1.29
Quarterly Revenue Growth (yoy)11,461.90%
Gross Profit (ttm)N/A
EBITDA -466.45M
Net Income Avi to Common (ttm)-538.26M
Diluted EPS (ttm)-3.23
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)519.69M
Total Cash Per Share (mrq)2.91
Total Debt (mrq)1.73B
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)6.37
Book Value Per Share (mrq)-5.87

Cash Flow Statement

Operating Cash Flow (ttm)-602.93M
Levered Free Cash Flow (ttm)-396.68M